Please fill out the contact form below and we will reply as soon as possible.
Withdrawal management alone is not an effective treatment for opioid use disorder, and offering this as a standalone option to...
February 6th, 2025 38 views 0 likes
Compared to placebo, alpha2-adrenergic agonists (e.g., clonidine, lofexidine, guanfacine, tizanidine) have been found to be effective for reducing the severity...
February 6th, 2025 44 views 0 likes
Like tapering off opioids with methadone, an opioid agonist taper involving buprenorphine/naloxone appears to reduce the severity of withdrawal symptoms,...
February 6th, 2025 41 views 0 likes
Tapering off opioids with methadone appears to reduce the severity of withdrawal symptoms; however, the majority of patients still relapse...
February 6th, 2025 31 views 0 likes
Given that withdrawal management alone is not recommended, it is the consensus of the committee that, in cases where it...
February 6th, 2025 45 views 0 likes
Psychosocial treatment interventions appear to be beneficial adjuncts to opioid withdrawal management.320 When offered in addition to pharmacologically-supported withdrawal management...
February 6th, 2025 37 views 0 likes
As detailed below, this guideline recommends against withdrawal management alone. For patients who expressly wish to pursue withdrawal management, slow...